BREN-02 / BrainEver - LARVOL DELTA

BrainEver Receives FDA Orphan Drug Designation for BREN-02, (human recombinant Engrailed 1) for the Treatment of Amyotrophic Lateral Sclerosis (ALS) (Businesswire) - “BrainEver…announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to its product BREN-02, the recombinant human homeoprotein Engrailed 1 (rhEN1), for the treatment of amyotrophic lateral sclerosis (ALS).”

Orphan drug • Amyotrophic Lateral Sclerosis • CNS Disorders